Investing In CBD Stocks Offers Opportunity But Risks

Cannabidiol has taken off lately, and the recent passage of the Farm Act in December has accelerated interest in the cannabinoid found in cannabis plants that was also the active ingredient in the first FDA approved drug derived from botanical cannabis, GW Pharmaceuticals's Epidiolex, which is indicated for the treatment of seizures in treatment-resistant forms of two types of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome.

The recent Farm Act that legalized industrial hemp was supposed to clear the path for the sale of CBD from industrial hemp, but this is only at the federal level. It turns out that states must create legislation to govern hemp production and the commercialization of hemp.

Gottlieb had recently announced that the agency would hold public hearings on the issue in April. His pending departure throws into question how this will all play out, so uncertainty will persist for a while.With the tremendous growth in the market, investors have expressed keen interest in CBD, and the number of publicly-traded stocks has skyrocketed.

starzwithfeet Invest in THC - that’s better

shall review

You don’t say

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Source: MarketWatch - 🏆 3. / 97 Read more »

With CBD, Cannabis Wellness Market Goes BigSales of CBD are predicted to hit $22 billion in 3 years—and much of that projected growth is coming from CBD’s newly minted status as a health and wellness product Even agrees, Shalini_bh and we are not allowed to purchase it in South Dakota🙁 just wait till there is a federal tax on that.
Source: Forbes - 🏆 394. / 53 Read more »

FDA chief Scott Gottlieb's resignation leaves 'billion-dollar question' for CBD industryJust a week ago, it looked like the Food and Drug Administration was ready to revisit its policies around CBD-infused food and drinks. Coors cannabis JV partner HEXO creating Truss Beverages 🍺
Source: CNBC - 🏆 12. / 72 Read more »

This investing app lets anyone with $50 invest in companies that make money by doing goodSwell is an impact investing app that's based on the idea that today’s biggest challenges will result in tomorrow’s leading industries.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Source: MarketWatch - 🏆 3. / 97 Read more »